SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-057481
Filing Date
2024-05-10
Accepted
2024-05-10 09:04:04
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-10

Document Format Files

Seq Description Document Type Size
1 ARS ars_10k_for_proxy.pdf ARS 616092
  Complete submission text file 0000950170-24-057481.txt   849905
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35610 | Film No.: 24933045
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)